Check out recent PlatformQ Health News
Hosted by National Organization for Rare Disorders (NORD®) and PlatformQ Health, this new annual digital conference featured the latest medical education from top experts on rare blood disorders, leukemias, lymphomas and rare solid tumors. The digital Rare Cancer Congress, held on October 28th and November 12th, engaged community-based clinicians and...
November's issue coincides with annual meeting of the world's largest professional society in hematology PlatformQ Health Education is pleased to announce the publication of three of our outcomes-evaluation abstracts in conjunction with the upcoming 62nd American Society of Hematology (ASH)_Annual Meeting and Exposition. The abstracts are published and available to...
Partners present findings from an outcome-centric joint educational initiative that showcases the impact rare disease education can have on improving health outcome. PlatformQ Health’s partnership with the National Organization for Rare Disorders (NORD) and CureSMA cultivated a successful educational program that led to the poster presentation, “Educational Impact of Digital...
Clinicians Love Learning with PlatformQ Health
This activity has allowed me to better do a differential diagnosis between various neuropathies, some of them very similar in symptom presentation.
Clinician learners after participating in Treatment Updates on Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)
After viewing these presentations, I can make use of more tools and alternatives to better explain their disease, and to talk with my patients about other treatment approaches.
Clinician learners after participating in AHA Conference Coverage Heart Failure Virtual Symposium (Clinical Spotlight on Novel Interventions for Patients with Heart Failure)
I am better at adjusting insulin therapy and individualizing the diabetic program for the patient.
Clinician, after participating in Long-acting Insulins In Treatment Of T2dm: Aligning Provider & Patient Perspectives To Address Therapeutic Barriers
I am more competent in prescribing the appropriate drugs. I also know how to involve my patients in health decisions to minimize non adherence.
Clinician, after participating in HIV Update: Adherence Advances with New ART Formulations
Leverage Our Learning Platform
Learn more about the PlatformQ Health Education solution and how to support CME/CE.